Navigation Links
STAAR Surgical Reports 19% Revenue Growth Second Quarter
Date:8/2/2011

aids, deposits, and other current assets1,7541,715   Total current assets32,77529,986Property, plant, and equipment, net3,4193,732Intangible assets, net3,2963,672Goodwill1,7861,786Deferred income taxes202202Other assets1,1661,207   Total assets$  42,644$
40,585LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Line of credit$
2,480$
2,460Accounts payable3,4523,717Deferred income taxes326326Obligations under capital leases 393431Other current liabilities5,7376,513   Total current liabilities12,38813,447Obligations under capital leases 1,3411,403Deferred income taxes606488Other long-term liabilities2,7612,820Total liabilities17,09618,158Stockholders' equity:Common stock355351Additional paid-in capital154,108152,014Accumulated other comprehensive income1,9622,100Accumulated deficit(130,877)(132,038)   Total stockholders' equity25,54822,427Total liabilities and stockholders' equity$  42,644$
40,585STAAR Surgical CompanyCondensed Consolidated Statements of Operations(In 000's except for per share data)Three Months EndedSix Months Ended% ofJuly 1,% ofJuly 2Change% ofJuly 1,% ofJuly 2ChangeSales2011Sales2010Amount%Sales2011Sales2010Amount%Net sales100.0%

$
,269100.0%

$
3,639$
2,63019.3%100.0%

$
31,118100.0%

$
27,417$
3,70113.5%Cost of sales33.2%

5,40836.4%

4,9604489.0%34.2%

10,62836.1%

9,9097197.3%Gross profit66.8%

10,86163.6%

8,6792,18225.1%65.8%

20,49063.9%

17,5082,98217.0%Selling, general and administrative expenses:  General and administrative25.2%

4,09824.0%

3,26883025.4%24.5%

7,62824.3%

6,65797114.6%  Marketing and selling25.8%

4,20030.3%

4,134661.6%27.8%

8,65929.1%

7,9656948.7%  Research and development8.6%

1,39310.1%

1,376171.2%9.1%

2,82510.6%

2,909(84)-2.9%  Other general and administrative expenses0.0%

-5.1%
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000
2. STAAR Surgicals nanoFLEX™ Collamer® IOL Receives CE Mark Approval
3. STAAR Surgical Launches Second Phase of Visian ICL Direct-to-Consumer Advertising Campaign
4. STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia
5. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
6. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
7. STAAR Surgical Reports Continued Double Digit Core Revenue Growth
8. STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS
9. STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
10. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
11. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – ... - http://photos.prnewswire.com/prnh/20140828/140879 ) The ... Poland " an essential source of information and ... and provides insights into the demographic, regulatory, reimbursement ... provides valuable insights into the trends and segmentation ...
(Date:8/28/2014)... Aug. 28, 2014 Takeda Pharmaceutical Company ... commitment and submissions of data from a 10-year ... the United States (U.S.) Food and ... and the Japanese Ministry of Health, Labour, and ... Devices Agency (PMDA) for pioglitazone containing medicines, including ...
(Date:8/28/2014)... 28, 2014  In anticipation of the upcoming MEDevice ... available for the first time. Industry Overview: Medtech & ... offers a snapshot of San Diego,s ... from the latest employment statistics to current venture capital investment ... Diego such a vital part of the global ...
Breaking Medicine Technology:Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2
(Date:8/28/2014)... Dallas, TX (PRWEB) August 29, 2014 ... and in-depth study on the current state of the ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/28/2014)... of women who are given information about the chance ... not fully understand the risks involved, according to research ... , today (Friday). , In a survey of around ... London (UCL) found that 64 per cent felt they ... chance that screening will pick up cancers that would ...
(Date:8/28/2014)... 2014 Arizona State University graduate student ... has been named one of five finalists in Entrepreneur ... This is the fourth consecutive year that an ASU ... Schoepf, co-founder of SafeSIPP, and JJ Tang, co-founder of ... In 2011, ASU dominated the competition: Three of the ...
(Date:8/28/2014)... exit strategy from the war, now may be the time ... to veterans, says a Perspective piece in the New ... doing more of the same is to fail to recognize ... structure pose in the longer run," said William Weeks, from ... David Auerbach, from the RAND Corporation, in the August issue ...
(Date:8/28/2014)... Allegheny Health Network and ... designed to advance sports nutrition education, concussion awareness ... scholastic athletes and their families across western Pennsylvania. ... Initiative will offer a comprehensive and multi-disciplined educational ... dynamics involved in pursuing athletic excellence,” said Come ...
Breaking Medicine News(10 mins):Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 2Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 3Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 3Health News:A VA exit strategy 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 3Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 4
... March 10 Speaker Nancy Pelosi and Majority Whip James E. Clyburn held a photo opportunity this afternoon with representatives from the National Association of Public ... ... ... ...
... uncovered a mechanism for resistance to paclitaxel in ovarian ... chemotherapy resistance. Mohamed K. Hassan, Ph.D., a ... research as a collaborative study with his colleagues when ... in Egypt. Results of this study were presented at ...
... treating tumors with extreme heat or moderate heat may ... presented at the second AACR Dead Sea International Conference ... the Clinic, held March 7-10, 2010. "Low ... in curing both malignant and benign tumors using minimally ...
... , March 10 Omega Protein Corporation (NYSE: OME ), the nation,s leading producer of Omega-3 fish oil and specialty fish meal ... with net income of $12.6 million ( $0.69 per share) for the year ended December 31, 2008 . , ... ... ...
... 10 International Merchant Advisors, Inc. (PK: IMAI) ... announced today that the company is preparing to ... Organic Science, Inc.  Organic Science, Inc. is intended to become ... and is focused on the implementation of Organic,s  plans for ...
... March 10 As part of its continued focus on developing programs designed to meet employers, needs, Regence has acquired the assets of Kinetix Living Corp., ... ... , ... ...
Cached Medicine News:Health News:Pelosi Remarks at Photo Opportunity with the National Association of Public Hospitals 2Health News:Omega Protein Reports 2009 Results 2Health News:Omega Protein Reports 2009 Results 3Health News:Omega Protein Reports 2009 Results 4Health News:Omega Protein Reports 2009 Results 5Health News:Omega Protein Reports 2009 Results 6Health News:Omega Protein Reports 2009 Results 7Health News:Omega Protein Reports 2009 Results 8Health News:International Merchant Advisors to Complete Purchase of Medical Marijuana Company Organic Science, Inc. 2Health News:International Merchant Advisors to Complete Purchase of Medical Marijuana Company Organic Science, Inc. 3Health News:Regence Invests in Kinetix Living Corp. 2Health News:Regence Invests in Kinetix Living Corp. 3
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking....
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis...
Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Acuity Vergence: Letter Acuity, Astigmatic,Clock, and Vergence Tests...
Medicine Products: